lapatinib has been researched along with methotrexate in 9 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 41,593 | 5,666 | 11,969 |
Protein | Taxonomy | lapatinib (IC50) | methotrexate (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 1.8 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
Thymidylate synthase | Homo sapiens (human) | 0.343 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
Folate receptor beta | Homo sapiens (human) | 0.1585 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Reduced folate transporter | Homo sapiens (human) | 0.012 | |
Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
1 review(s) available for lapatinib and methotrexate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for lapatinib and methotrexate
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |